News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Myeloma Paper of the Day, June 4th, suggested by Robert Orlowski
Jun 4, 2024, 14:44

Myeloma Paper of the Day, June 4th, suggested by Robert Orlowski

Robert Orlowski shared on X:

“Myeloma Paper of the Day: Phase III BENEFIT trial shows addition of bortezomib to isatuximab/lenalidomide/dexamethasone for transplant-ineligible myeloma patients improves CR rate (33% vs. 58%) and MRD-negativity (26% vs. 53%)(the primary endpoint).”

Source: Robert Orlowski/X

Isatuximab, lenalidomide, dexamethasone and bortezomib in transplant-ineligible multiple myeloma: the randomized phase 3 BENEFIT trial

Authors: Xavier Leleu, et al.

Myeloma Paper of the Day, June 4th, suggested by Robert Orlowski

Other posts featuring Robert Orlowski on OncoDaily.

Robert Orlowski holds multiple positions at The University of Texas MD Anderson Cancer Center, including Chairman, Ad Interim Director of Myeloma, and Professor of Medicine in the Departments of Lymphoma/Myeloma and Experimental Therapeutics within the Division of Cancer Medicine.

Additionally, he chairs the SWOG Barlogie/Salmon Myeloma Committee, which is part of the National Clinical Trials Network, dedicated to advancing new therapies and understanding the biology of myeloma.

Agathe Waultier-Rascalou Alberto Santagostino Amine Kasmi Arthur Bobin Aurore Perrot BENEFIT trial Benoit Bareau Bertrand Arnulf Bertrand Joly Borhane Slama Bortezomib Brieuc Cherel Bruno Royer cancer Celine Kennel Christophe Roul Claire Calmettes Claire Dingremont Clara Mariette Cyrille Hulin Cyrille Touzeau Daniela Robu-Cretu dexamethasone Emilie Chalayer Emmanuelle Bourgeois Florence Lachenal François Vergez Frederique Orsini-Piocelle Helene Demarquette Helene Gardeney Hervé Avet-Loiseau Isatuximab Jacques Delaunay Jean-Sebastien Bladé Jerome Lambert Jill Corre Julie Gay Kamel Laribi Karim Belhadj Laure Vincent Laurent Frenzel Laurent Garderet Lenalidomide Lionel Karlin Lydia Montes Mamoun Dib Margaret Macro Marie-Lorraine Chretien MD Anderson Cancer Center Mohamad Mohty Mourad Tiab multiple myeloma Muriel Newinger-Porte Murielle Roussel Myeloma Paper of the Day Noemie Bigot Olivier Decaux OncoDaily Oncology Philippe Moreau Pierre Lebreton Rakiba Belkhir Reza Tabrizi Robert Orlowski Ronan Le Calloch Salomon Manier Selim Corm Sophie Rigaudeau Thierry Facon Thomas Chalopin Thorsten Braun Valentine Richez-Olivier Xavier Leleu
Special Coverage
Blog
Nov 12, 2024, 23:10
Hesham ElGhazaly: Empowering Women’s Health Through Solidarity
Blog
Nov 12, 2024, 23:07
Helen’s Journey with Breast Cancer - The Max Foundation
Blog
Nov 12, 2024, 22:58
Webinar on Lung Cancer Highlights from ESMO 2024 - SPCC
Blog
Nov 12, 2024, 22:56
Sanjay Juneja: The Challenge of Innovation in Cancer Treatment
Blog
Nov 12, 2024, 22:52
Session on cervical cancer screening programs and managing cervical pre-cancer in women living with HIV at IPVC 2024 - IARC
Blog
Nov 12, 2024, 22:50
Penilla Gunther: First time speaking at the POLITICO Europe Healthcare Summit
Blog
Nov 12, 2024, 22:46
Addressing AMR for Better Cancer Care During London Global Cancer Week - UICC
Blog
Nov 12, 2024, 22:43
Applications Open for 2025 CancerX Accelerator - CancerX Moonshot
Blog
Nov 12, 2024, 22:40
Wafik S. El-Deiry: Welcoming Dr. Dinara Ryspayeva to Brown University for Therapeutic Advances in Oncology
Celebrities
Nov 12, 2024, 19:50
Mark Ruffalo and Brain Cancer: How He Went Against, How He Survived, and More
Blog
Nov 12, 2024, 19:38
Alfredo Colina on comparing real-time multimodal analysis of CAR-T cells to more traditional phenotypic and functional assays
Insight
Nov 12, 2024, 19:34
5 papers about Lung Cancer suggested by Stephen Liu